생명과학회지 (Journal of Life Science)

  • 제23권2호
  • /
  • Pages.207-212
  • /
  • 2013
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

Resveratrol에 의한 cysteine-rich angiongenic inducer 61 (CYR61) 유전자의 과대발현 조절

Resveratrol Up-regulates Cysteine-rich Angiogenic Inducer 61 (CYR61) in Human Colorectal Cancer Cells

  • 곽은희 (안동대학교 자연과학대학 생명과학과) ;
  • 김종식 (안동대학교 자연과학대학 생명과학과)
  • Kwak, Eun-Hee (Department of Biological Sciences, Andong National University) ;
  • Kim, Jong-Sik (Department of Biological Sciences, Andong National University)
  • 투고 : 2012.11.19
  • 심사 : 2013.01.25
  • 발행 : 2013.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

파이토케미칼 resveratrol은 항산화, 항염증, 항암등을 포함하는 다양한 생리활성을 가지고 있는 것으로 알려져 있다. 본 연구에서는 resveratrol이 CCN family 중의 하나인 cysteine-rich angiogenic inducer 61 (CYR61) 유전자의 발현을 유도할 수 있는지 연구하였다. 결과에 의하면 resveratrol은 3개의 다른 인간 대장암 세포주에서 CYR61 단백질의 발현을 유도하였을 뿐만 아니라, HCT116세포주에서는 처리한 resveratrol 농도와 시간 의존적으로 CYR61 단백질의 발현을 유도하였다. 이러한 CYR61 단백질의 발현이 resveratrol의 어떤 생리활성과 관련이 있는지 확인하기 위하여 몇 종류의 NSAIDs와 항산화제를 처리하여 CYR61 단백질의 발현을 확인하였으나, 오직 resveratrol의 처리에 의해서만 CYR61 단백질의 발현이 유도되었다. 또한, CYR61의 발현은 암 억제유전자인 p53과는 관련이 없는 것으로 판단되었다. Promoter assay를 통하여 프로모터 -732 ~ +54 사이에 조절부위가 있음을 확인하였고, 파이토케미칼 Indole-3-carbinol이나 6-gingerol에 의해서도 CYR61의 발현이 유도되지 않음을 확인하였다. 이러한 연구결과는 resveratrol에 의한 CYR61 유전자의 발현은 resveratrol특이적이며, 이러한 연구결과는 resveratrol만의 특이한 생리활성을 이해하는데 도움을 줄 것으로 기대된다.

In this paper, we investigated whether resveratrol could induce the expression of cysteine-rich angiogenic inducer 61 (CYR61), which is a member of the CCN families. We showed that resveratrol up-regulated CYR61 protein expression in three different human colorectal cancer cell lines. In addition, resveratrol induced CYR61 protein expression in a dose- and time-dependent manner in a HCT116 cell line. To investigate the relationship between various biological activities of resveratrol and CYR61 expression, HCT116 cells were incubated with several NSAIDs, antioxidants, or resveratrol. Interestingly, resveratrol only induced CYR61 protein expression. The expression of CYR61 was not related to the presence of p53. A promoter assay revealed that the 786-bp promoter region (-732/+54) contains a regulatory region and that indole-3-carbinol and 6-gingerol could not induce CYR61 expression. In conclusion, our results indicate up-regulation of CYR61 is extremely resveratrol specific. The results can help to shed light on the unique biological function of resveratrol.

키워드

참고문헌

  1. Baek, S. J., Wilson, L. C. and Eling, T. E. 2002. Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis 23, 425-434. https://doi.org/10.1093/carcin/23.3.425
  2. Bavaresco, L. 2003. Role of viticultural factors on stilbene concentrations of grapes and wine. Drugs Exp Clin Res 29, 181-187.
  3. Brigstock, D. R. 2003. The CCN family: a new stimulus package. J Endocrinol 178, 169-175. https://doi.org/10.1677/joe.0.1780169
  4. Chien, W., Kumagai, T., Miller, C. W., Desmond, J. C., Frank, J. M., Said, J. W. and Koeffler, H. P. 2004. Cyr61 suppresses growth of human endometrial cancer cells. J Biol Chem 279, 53087-53096. https://doi.org/10.1074/jbc.M410254200
  5. Chung, E. Y., Kim, B. H., Hong, J. T., Lee, C. K., Ahn, B., Nam, S. Y., Han, S. B. and Kim, Y. 2011. Resveratrol down-regulates interferon-γ-inducible inflammatory genes in macrophages: molecular mechanism via decreased STAT-1 activation. J Nutr Biochem 22, 902-909. https://doi.org/10.1016/j.jnutbio.2010.07.012
  6. Chuang, J. Y., Yu, N. Y., Chiang, I. P., Lai, C. H., Lin, C. D. and Tang, C. H. 2012. Cyr61 increases matrix metalloproteinase- 3 expression and cell motility in human oral squamous cell carcinoma cells. J Cell Biochem 113, 1977-1986. https://doi.org/10.1002/jcb.24066
  7. Delmas, D., Lançon, A., Colin, D., Jannin, B. and Latruffe, N. 2006. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr Drug Targets 7, 423-442. https://doi.org/10.2174/138945006776359331
  8. Dhar, A. and Ray, A. 2010. The CCN family proteins in carcinogenesis. Exp Oncol 32, 2-9.
  9. Kim, J. S., Jang, M. J., Kim, H. Y., Kim, S. Y. and Sohn, H. Y. 2007. Analysis of differentially expressed genes by resveratrol using membrane microarray. J Life Sci 17, 1115-1120. https://doi.org/10.5352/JLS.2007.17.8.1115
  10. Kim, Y. A., Lee, W. H., Choi, T. H., Rhee, S. H., Park, K. Y. and Choi, Y. H. 2003. Involvement of p21WAF1/CIP1, pRB, Bax and NF-kappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells. Int J Oncol 23, 1143-1149.
  11. O'Kelly, J., Chung, A., Lemp, N., Chumakova, K., Yin, D., Wang, H. J., Said, J., Gui, D., Miller, C. W., Karlan, B. Y. and Koeffler, H. P. 2008. Functional domains of CCN1 (Cyr61) regulate breast cancer progression. Int J Oncol 33, 59-67.
  12. Park, M. H., Kwak, E. H., Sohn, H. Y., Eling, T. E. and Kim, J. S. 2011. Global gene expression changes by several phytochemicals in human colorectal cancer cell. J Life Sci 21, 1219-1225. https://doi.org/10.5352/JLS.2011.21.9.1219
  13. Perbal, B. 2004. CCN proteins: multifunctional signalling regulators. Lancet 363, 62-64. https://doi.org/10.1016/S0140-6736(03)15172-0
  14. Rayalam, S., Yang, J. Y., Ambati, S., Della-Fera, M. A. and Baile, C. A. 2008. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother Res 22, 1367-1371. https://doi.org/10.1002/ptr.2503
  15. Rizvi, S. I. and Pandey, K. B. 2010. Activation of the erythrocyte plasma membrane redox system by resveratrol: a possible mechanism for antioxidant properties. Pharmacol Rep 62, 726-732. https://doi.org/10.1124/pr.110.002733
  16. Tong, X., O'Kelly, J., Xie, D., Mori, A., Lemp, N., McKenna, R., Miller, C. W. and Koeffler, H. P. 2004. Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta- catenin-c-myc-p53 pathway. Oncogene 23, 4847-4855. https://doi.org/10.1038/sj.onc.1207628
  17. Udenigwe, C. C., Ramprasath, V. R., Aluko, R. E. and Jones, P. J. 2008. Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr Rev 66, 445-454. https://doi.org/10.1111/j.1753-4887.2008.00076.x
  18. Vogelstein, B., Lane, D. and Levine, A. J. 2000. Surfing the p53 network. Nature 408, 307-310. https://doi.org/10.1038/35042675
  19. Whitlock, N. C., Bahn, J. H., Lee, S. H., Eling, T. E. and Baek, S. J. 2011. Resveratrol-induced apoptosis is mediated by early growth response-1, Krüppel-like factor 4, and activating transcription factor 3. Cancer Prev Res (Phila) 4, 116-127. https://doi.org/10.1158/1940-6207.CAPR-10-0218